Currently viewing the category: "GlaxoSmithKline"

FDA confirms safety risk of Avandia

By · Leave a Comment

Although we already know why Avandia is still on the market, the FDA released the preliminary results of its evaluation of the GlaxoSmithKline drug. Here are the results via the Washington Post:

The government’s own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier [...]

Continue Reading →

PBS obesity program under fire

By · 1 Comment

On April 11, PBS plans to broadcast “Fat: What No One is Telling You” — a program sponsored by GlaxoSmithKline.

Jeff Chester, executive director of the Center for Digital Democracy, comments:

The drug giant just happens to have a recently approved for over-the-counter drug on the market — [...]

Continue Reading →